Biopharma

Open Innovation Event Webinar

10:00 – 10:15 AM | Opening by Andy Topping, CSO, FUJIFILM Diosynth Biotechnologies 10:15 – 10:45 AM | Real Time Metabolomics in Biotechnology and Biopharma | Karl Burgess, Senior Lecturer...

Aug 06, 2020
10:00 am – 2:00 pm
- Biopharma
- Biotech + Life Sciences
Nine CEOs signed a pledge outlining a united commitment to sustain the integrity of the scientific process as they work toward potential regulatory filings and approvals of the first COVID-19 vaccines.
- Biopharma
- Biotech + Life Sciences
Bayer has entered a collaboration agreement with Recursion Pharmaceuticals to strengthen AI-guided drug discovery and advance new treatments for fibrotic diseases of the lung, kidney, heart, and more.
- Biopharma
Moderna CEO sees ‘high probability’ of success with Covid-19 vaccine

Recent history suggests a new vaccine entering human clinical trials has about a 1-in-3 chance of getting FDA approval. Stephane Bancel, chief executive of Moderna, pegs the chances of his company’s novel coronavirus vaccine at closer to 80% to 90%.